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Abstract 
Coronary heart disease (CHD) is responsible for considerable morbidity and 
morality. Research over the past decades has clarified traditional risk factors such a high 
cholesterol, elevated blood pressure, obesity, or smoking. Recent research has begun 
exploring controversial relationships between CHD and potential risk factors such as lack 
of social support, social isolation, depression, Type A behavior, and hostile 
temperaments. Due to lack of power or methodological flaws these studies have been 
unable to establish consistent findings or clarify a theoretical basis for observed 
correlations. This paper surveys traditional risk factor interventions, provides a brief 
summary of the literature on the social risk factors, and proposes an exploratory study to 
investigate a conceptual model of CHD progression and potential risk factors. The 
proposed study builds from the strengths of the ENRICHD trial and addresses its 
weakness while providing a comprehensive data set for exploring risk factor interactions. 
Understanding these interactions within a conceptual model would serve as the basis for 
further effectiveness trials that would translate to clinical practice. 
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Coronary Heart Disease (CHD) is the single largest cause of death for American 
males and females. Given current rates, about every 26 seconds someone will suffer a 
coronary event, and about every minute someone will die from one. Of those that 
experience a coronary attack, about 42% will die within a year. 1•3•4 
This paper is an analysis of current studies that investigate the relationship of 
social support and CHD in men, and a proposal for a pilot study to clarify the ambiguities 
of this relationship. This first section will survey the risk factors, burden, and preventive 
strategies for CHD in this population. The following sections will analyze the current 
literature on social interventions for this condition in the males, and outline the 
justifications and format of the pilot study. 
Generally accepted risk factors for CHD include hypertension, 
hypercholesterolemia, smoking, diabetes, physical inactivity, obesity, and age. The 
majority of papers analyzing the above risk factors has been cross-sectional and has 
demonstrated a relationship between the presence of the risk factors and CHD. The 
studies have not been able to determine how well these risk factors correlate with the 
degree of CHD, nor the rate of progression. A recent paper by Phillips et al. analyzed the 
major predictors of CHD in men. Their study concluded that age, high-density lipoprotein 
(HDL-C) and free testosterone were the strongest predictors of degree of CHD in men2 
Further research may clarify this relationship. 
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Due to large studies such as the landmark Framingham study, we have been able 
to obtain large cross-sections of the American population and follow health behaviors or 
risk factors as related to coronary disease. Continuing study has clarified more risk 
factors such as high levels of homocysteine and a possible link with microbial infection. 
The American Heart Association issues an annual update of known risk factors and 
stratifies them according to race. The table below outlines the prevalence of these risk 
factors for American 
males: 13.0 M (6.9%) 7_1 M (8.4%) 8.9% 7.4% 5.6% 
1.2M 715.0K 650.0 K 65.0K --·~-
502.2 K 254.0 K 224.5 K 24.6 K ----~ 
65.0M 32.3% 30.6% 41.8% 27.8% 
In 2001 the 
49.7 K 20.5 K 14.7 K 5.3 K 
prevalence of CHD was 48.1 M 25.6M 25.1% 27.6% 
{22.8%) {2.5%) 
comparable between 
races, yet nearly ten 106.9M 50.4 M 51.0% 37.3% 54.3% 
(50.7%} (50.4%) 
times as many whites 37.7M 16.9M 17.8% 10.6% 17.8% (18.3%) {17.2%} 
95.0M 48.6M 49.6% 46.3% 43.6% 
died ofCHD. Whites (45.8%) (48.5%) 
54.7M 38.0M 40.5% 24.3% 40.1% 
(26.4%) (39.0%) 
had higher total 38.6% 35.8% 34.4% 45.1% 
cholesterol and lower 
amounts ofHDL-C. 13.9M 6.8M 6.2% 10.3% 10.4% 
(6.7%) (7.2%) 
Almost 10% more 5.9M 2.9M 3.0% 1.3% 3.5% (2.8%) {2.9%) 
14.5 M (7.0%) 8.5M 8.6% 8.3% 8.7% 
blacks have high blood (8.9%) 
73.2 K 34.3K 28.1 K 5.2 K 
pressure. Larger 
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proportions of Hispanics were overweight and nearly 28% of men in all races were obese. 
Other studies in obesity may disagree with these measures. More blacks and Hispanics 
have diabetes, and again whites have greater mortality resulting from the disease_3.4 
Although researchers have not been able to correlate the risk factors with severity 
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of disease, they have been able to determine the relative risk of developing CHD based 
upon the presence or absence of the factors. According to the World Health Organization 
(WHO), the risk of CHD decreases by 50 percent one year after quitting smoking and the 
relative risk approaches that of a lifetime nonsmoker after fifteen years. Nearly 35,000 
nonsmokers die from CHD each year as a result of exposure to environmental tobacco 
smoke5 Patients may achieve a 30 percent reduction in the incidence of CHD with a I 0 
percent reduction in total cholesterol. 6 Those men with low HDL-C and high total 
cholesterol have the highest risk of heart attack, and those men with levels above 37 
mg/dL are at high risk even with normal total cholesterol. 3 4 Physical inactivity carries a 
1.5 to 2.4 relative risk for CHD, an increase that is comparable to that observed for high 
blood pressure, high blood cholesterol, or cigarette smoking7 
There is an inverse relationship between socioeconomic status (SES) and CHD. 
Although mortality for CHD has declined since the 1960's this decline has not affected 
all segments of society equally. Low-income persons living in the most disadvantaged 
neighborhoods had hazard ratios of 3 .I (whites) and 2.5 (blacks) compared with high-
income persons in the most advantaged neighborhoods. 8 There has generally been an 
inverse relationship between SES indicators and hypertension, smoking, total cholesterol, 
body mass index, excess alcohol use, and sometimes diabetes. The most striking 
relationships are with smoking and hypertension. The relationship between SES and 
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cardiovascular disease has been widening, and accounting for the many confounding 
variables in studying these effects is challenging.2 Further research will need to 
understand this interdependent system. 
There are many component causes that contribute to developing CHD, and there 
are multiple interventions to address this progression. Screening modalities including 
ECG, cholesterol measurements, glucose levels and blood pressure are methods to 
identify high-risk patients and even monitor the disease course as a proxy. Medications 
that improve lipid profiles, lower blood pressure, and inhibit platelet aggregation provide 
effective chemoprevention. Lifestyle habits such as physical inactivity and smoking 
behaviors may be amenable to change through intensive individual interventions, public 
education, and public policies that support healthy practices. 
Interventions with Traditional Risk Factors 
It seems logical that to effectively prevent CHD, a multifaceted intervention that 
addresses multiple risk factors would be the most effective. Many countries have 
attempted such primary prevention programs using a multiple risk factor intervention in 
the belief that such an approach would be effective and would lower costs. These plans 
have utilized combinations of counseling, education, and pharmacotherapy in both the 
primary care setting and in the workplace. The degree of risk factor control appeared to 
correlate with the reduction in disease incidence. Quasi-experimental studies such as the 
North Karelia Project and seemed to provide evidence in support of this multiple risk 
factor intervention. 9 
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More recent studies have brought these observations and assumptions under 
question. New evidence has stimulated a review of the methodology for multiple risk 
factor interventions within the primary care setting and within the community. 
Performing a meta-analysis has been difficult due to the vast heterogeneity of the 
interventions, insufficient detail in reporting, and sometimes poor study design. In 1995 
the Cochrane Collaboration performed a systematic review of multiple risk factor 
interventions for primary prevention of CHD. They have periodically updated this review 
and the most recent update was on May 281h, 2003.9 
The Cochrane review demonstrated that multiple risk factor interventions were 
costly and ineffective for primary prevention of CHD in low-risk patients. The review 
focused on multiple risk factor interventions consisting of counseling, education, and 
pharmacotherapy in one-to-one or family-oriented settings. The study did reveal a 
positive effect for patients with hypertension, elevated cholesterol, or significant levels of 
other risk factors. Baseline levels of risk factors were strong predictors of the net falls 
experienced, thus suggesting that a multiple risk factor intervention might be more 
effective in targeted high-risk populations. 
CHD is a major contributor to morbidity and mortality in the US. It represents a 
significant financial burden to individuals, the workplace, and to the health care system. 
Research has demonstrated that multiple risk factor interventions are ineffective in the 
primary prevention of CHD in low risk individuals. Interventions focusing on policy, 
community planning, targeted group settings, high-risk individuals, or national education 
may be more effective. The following section will survey the research investigating the 
dynamics of social support in this paradigm. 
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Summary of Literature for Social Support and CHD 
For this swnmary, the author searched Medline utilizing the search terms: 
Coronary Heart Disease, Coronary Artery Disease, CHD, CAD, Social Support, 
Emotional Support, Instrumental Support, and Perceived Social Support. The search was 
limited to human studies reported in the English language between January of 1975 and 
March of2005. This search yielded 41 pertinent articles, and further limiting the search 
to males restricted the pool to 19 articles. A full systematic review is beyond the scope of 
this paper. Findings from the pertinent articles are detailed below. 
Researchers have investigated the relationship between low social support and 
cardiac outcomes due to CHD. Ruberrnan et a!. noted that men with low perceived social 
support and high life stress were more than 4 times as likely to die after a myocardial 
infarction (MI.) 10 Gorkin eta!. demonstrated that the level of perceived social support 
was a significant multivariate predictor of mortality in high stress men. 11 Orth-Gomer et 
a!. noticed that socially isolated men with CHD had 3 times the rate of total mortality in 
comparison to non-isolated men. Married men are significantly less likely to die post MI 
during hospitalization or follow up. 12 13 14 Living alone is an independent risk factor for 
mortality post MI.15 Other researchers have uncovered that a lack of social support in 
itself is associated with increased morbidity and mortality in patients with CHD .16 
Accounting for other risk factors, lack of social support has been shown to predict 
cardiovascular morbidity and mortality. 17 18 19 Of social support types, emotional support 
has the strongest influence on CHD?0 21 
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In combination with other risk factors low social support has demonstrated a L 
' 
synergistic effect that researchers have yet to understand. Depression is an independent L 
risk factor for morbidity and mortality post MI. Low social support is directly correlated 
with depressive symptoms one month after hospitalization when controlling for baseline 
;__ 
depression, gender, disease severity, and age.22 The potential for hostile behavior predicts 
recurrent CHD events. Cynical hostility as depicted by an attitude of resentment, distrust, 
cynicism, and suspicion predicts CHD progressionn Low social support and high 
hostility together increase risk of cardiac morbidity and mortality. 24 Hostility may be an 
indirect predictor of CHD by means of its effect on social support, and low social support 
may have indirect effects through its influence on depression22 Researchers are working 
to determine the direct and moderating effects of social support on cardiac outcomes. The 
below subsections attempt to group the heterogeneous literature by topic in order to 
clarify current research findings and directions for future study. 
Social Isolation 
Brummet et al. utilized the longitudinal data from the Moderators of Social 
Support (MOSS) Study to investigate the relationship of social isolation and cardiac 
mortality. 25 Previous research had noted that psychological distress was a risk factor for 
cardiac mortality in patients with CHD, and that this distress was more severe in patients 
who feel that they lack social support.22 26 27 28 They used the Mannheim Social Support 
Interview to determine network social support. They then monitored the following 
variables to determine correlations and independent effects: number of confidants, 
number of individuals in the household, perceptions of social support, participation in 
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religious activities, depression, functional status, health perceptions, mental health, 
activities of daily living, perceived stress, hostility, income, disease severity, smoking, 
and exercise status. Accounting for all other variables, social isolation as determined by 
low network social support predicted increased cardiac mortality as demonstrated by the 
risk ratio of2.11 with a 95% CI 1.39-3.19 (p< 0.0009) over the 24 months of the study. 
Isolated patients lacked confidants, were more likely to be unmarried, had little emotional 
support, and had lower perceptions of both social support and quality of relationships. 
Isolated patients had lower income and smoked more, both of which are risk factors for 
CHD; however, accounting for these variables did not significantly affect the risk ratio. 
Isolated patients had similar religious attendance, disease severity, depressive symptoms, 
and perceived stress in comparison to the socially connected. The isolated patients did 
demonstrate more hostility, yet accounting for this variable did not substantially affect 
the risk ratio (2.47 for cardiac mortality over 2 years). 
The researchers concluded that network support affects cardiac mortality and that 
the relationship is nonlinear: those with very few social connections had a 
disproportionate increase in risk. In rebuttal to contrary arguments, the authors 
demonstrated that the isolated patients were neither sicker, nor did they delay medical 
care. They noted that patients that would benefit from more social connection are the 
very patients that are difficult to enroll in psychosocial interventions and have a high 
attrition rate. Interventions hoping to address social isolation will need to address this 
enrollment challenge. 
]] 
Social Support and Hostility 
Brummet et al. investigated the relationship between trait hostility and 
perceptions of social support in predicting depressive symptoms at I month after 
hospitalization for diagnostic angiography.22 They hypothesized several mechanisms to 
explain these potential effects. Chronic increases in sympathetic nervous system (SNS) 
function can lead to myocardial electrical instability, platelet activation, and myocardial 
workload. In addition, depression and low social support have been associated with 
detrimental health behaviors. 22 
Through a study of 506 CHD patients they demonstrated an independent negative 
association of social support and depressive symptoms within the study parameters. They 
noted that hostility was a small, indirect predictor of postdischarge depressive symptoms 
by way of its negative effect on social support. This negative relation did not differ across 
gender, predicted risk classification, or age. They did not find evidence of hostility as an 
independent, direct predictor of depressive symptoms at 1 month. They commented that 
although hostility predicts initial coronary events, it does not seem to predict secondary 
events. 
Angerer et al. devised their study from the literature that observed a synergistic 
relationship between hostility and low social support in affecting cardiac outcomes?9 23 30 
31 Their study of 223 patients with CHD, documented by standardized angiography, 
showed a higher risk of progression for those that scored high on the State-Trait-Anger-
Expression Inventory (ST AXI) for outwardly expressed anger and who reported low 
social support. A multivariate analysis adjusting for confounding variables and 
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examining interaction with psychological variables showed that only patients with both 
high levels of outwardly expressed anger and low social support were at increased risk 
for progression (RR 3.19 over two years). They found that the quality of the social 
support, in particular the quality of emotional support, predicted the largest effect on 
CHD progression. The quantity of social support was a stronger predictor of mortality, 
but may reflect the availability of medical assistance. Cynical hostility was associated 
with the presence of CHD, yet it was not associated with progression. The authors note 
prior research in which all-cause mortality for highly cynical men has been moderated 
through coronary risk factors, and that intense treatment of these risk factors in their 
study may have leveled any differences with less cynically hostile men. 
Hostility, isolation and male sex may be dangerous combination. Researchers are 
attempting to understand the pathogenesis of this relationship, and to determine 
differences in subgroup populations. Interventions with populations of hostile men will 
be challenging by the nature of the population. Continued research in this field will assist 
the translation into clinical application. 
Social Relationships and Cardiac Reactivity 
Bloor et a!. commented that although many studies have demonstrated that low 
social support increases cardiac mortality, little is known about the underlying 
mechanisms?2 Based on prior research, they proposed cardiac reactivity as a potential 
physiologic mechanism. Exaggerated cardiovascular responses over time may increase 
CHD. Social support during acute stress reduces cardiovascular responses. In addition, 
recalling relationships through memory influences cardiac function. Their study of forty-
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three men and sixty-six women analyzed cardiac reactivity during prompted relationship 
recall. They hypothesized that aversive, indifferent, or ambivalent relationships would 
have higher cardiac reactivity during recall than supportive ones. They also predicted a 
gender difference in response. 
Their results did not support a difference in cardiac reactivity during recall of the 
four types of relationships; however, they did reveal gender differences in response. 
Contrary to the finding that men are generally more reactive to achievement-oriented 
laboratory task, women demonstrated a higher sympathetic activation upon recall. 
Women were also more responsive to the negative qualities of relationships. Overall, the 
women were more reactive to relationship-oriented topics. The authors were unsure why 
cardiac reactivity increased in similar ways for the recall of different types of 
relationships. They postulated that recall of especially positive relationships might have 
generated excitement or that recall bias might have influenced physiologic response. The 
physiologic link between sympathetic nervous system stimulation and CHD is 
scientifically sound. More research is necessary to determine if social support has a 
consistent role of influencing cardiac reactivity in this cascade. 
Social Support as Related to CHD and Quality of Life 
Bosworth et a!. examined the relationship between perceived social support and 
domain-specific health-related quality of life (HRQOL) in a sample of 4278 cardiac 
catheterization patients.33 Accounting for age, gender, race, education, and CHD severity, 
regression models indicated that a lack of social support was significantly associated with 
lower levels ofHRQOL across eight measured domains. The eight domains included: 
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physical function, physical role ftmction, bodily pain, general health, emotional role 
function, social function, mental health, and vitality. 
Variations in the subgroups offer insight and stimulate questions for future 
clinical applications. Social support played a more beneficial role for whites than for 
minorities, and in general minorities had higher levels of HRQOL. Minority patients with 
low social support had markedly higher levels of general health, social functioning, and 
mental health than whites with similar social support. When both the minorities and 
whites reported high levels of social support, these differences diminished. This finding 
raises the questions of whether low social support is more detrimental to whites, whether 
there are different perceptions of social support in minority communities, or even 
whether there are different baselines of social support between the communities. Females 
reported lower HRQOL across all domains, yet the authors proposed that this might be 
due to women's willingness to report symptoms. This study illustrates potential effects of 
social support on the HRQOL for patients living with CHD. With the increasing 
longevity of our population, more citizens will be living with CHD, and the resultant 
decreases in HRQOL due to the disease will be of increasing importance. It will be 
necessary to further investigate these questions in the relationship between CHD, social 
support, and HRQOL. Decreases in HRQOL may feed back to affect moderating 
variables of CHD progression such as depression, hostility, health behaviors, and social 
support. 
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Low Perceived Social Support, Depression, and CHD 
Investigators of the Enhancing Recovery in Coronary Heart Disease (ENRICHD) 
developed a large multi-center, randomized trial that aimed to determine whether 
treatment of depression and low perceived social support increases reinfarction-free 
survival after acute myocardial infarction. The study was an effectiveness trial that 
enrolled 2,481 participants of diverse race, sex, and socioeconomic backgrounds. The 
participants were randomized to individualized treatment for depression and/or low social 
support, or to standard medical care. 
Depression and low perceived social support (LPSS) after myocardial infarction 
are predictors for increased morbidity and mortality.34 No clinical trial had tested the 
effects of increasing social support and reducing depression on clinical endpoints 
following acute MI. Multiple studies have investigated the independent effects of each 
predictive variable. Researchers have demonstrated that depression is an important 
predictor of morbidity and mortality in CHD patients independent of previous cardiac 
history, CHD severity, or residual left ventricular function. Post-MI patients report a 
prevalence of major depression between 15 and 20%, and an additional 27% report 
symptoms of minor depression?' 34 36 Studies to improve social support that utilized 
group-based cognitive behavioral therapy and psycho-education, or individual nurse 
delivered home-based interventions have demonstrated lower mortality, fewer recurrent 
MI' s, and increased quality of social interaction. Some studies have been unable to 
replicate these results and demonstrated that those that responded early continued to 
improve while those that did not initially respond continued to worsen. Supporters of 
social support interventions note that the studies reporting no effect were often limited by 
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power or design and analysis flaws. 37 38 39 The ENRICHD trial was designed to have the 
power and execution to answer this debate. 
The investigators attempted to modify the intervention methods to meet the needs 
of different populations and individuals. This process of catering the intervention to the 
recipient reflected an appreciation of the complex web of mediating variables in social 
support and an effort to determine the optimal therapy for population subgroups. The 
investigators utilized a series of tools to discern a participant's level of depression, 
perceived stress, perceived social support, instrumental and emotional needs, and beliefs 
relating to social ties and network availability. In addition, they identified the degree of 
participant's social integration, current satisfaction with specific sources of support, and 
preference for different types of support. As one can see, their efforts to profile each 
participant's needs were remarkable. From this data they decided upon individual 
psychotherapy, group therapy, and pharmacotherapy consisting of an SSRI or 
nortriptyline. 
The researchers chose a Cognitive Behavioral Therapy (CBT) model based upon 
prior research demonstrating effectiveness in treating depression across diverse 
population, and for its ability to address perceptions of social support. Individual 
psychotherapy ranged from six sessions to a maximum of six months, depending on the 
patient's progress. Group therapy was contingent upon availability and ran for up to 
twelve weeks. Treatment for depression continued until the patient had a therapeutic 
response to counseling or medication. A modified form of the Perceived Social Support 
Scale (PSSS) measured progress in the domain of social support. Treatment for low 
perceived social support (LPSS) continued until the participant engaged in at least one 
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satisfying and supportive social relationship, was able to do 'self therapy,' and achieved a 
criterion score on the modified PSSS for at least two consecutive sessions. 
Researchers utilized creative means to bolster adherence in this complex 
intervention and population. At conclusion, they had a high retention rate of93.02% with 
those completing the study participating for a mean of28.3 months and those lost to 
follow-up averaging 19 months. The creative methods to assure this adherence rate and 
the ability to adapt the intervention to the diverse population represent strengths of this 
study. 
The investigators executed the study design well, and the results of this large trial 
have had a significant impact in the field of social support study. The treatment of LPSS 
and depression included the individually catered cognitive behavioral therapy and 
selective serotonin receptor inhibitors (SSRI's) when applicable. The study noted a 
marginal and statistically significant decrease in depression and LPSS, however was 
unable to demonstrate any significant difference in event free survival over the 29 month 
course of the study (p<O.OOI.) 
In contrast, an early study known as the Recurrent Coronary Prevention Project 
(RCPP), which used group-based cognitive behavioral therapy to reduce Type A 
behavior, decreased depression and improved the quality of social interaction. This 5-
year clinical trial randomized patients to one of three arms, including aggressive 
education with traditional pharmacotherapy, cognitive behavioral therapy, standard 
private practice, and then included a dropout comparison group voluntarily discontinuing 
therapy. The cognitive behavioral intervention decreased Type A behavior patterns as 
well as CHD morbidity and mortality_37 
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Comparing the two studies, the RCPP enrolled primarily white men (92%), while 
the ENRICHD trial enrolled a large percentage of women (44%) and minorities (34%.) 
Exploratory post hoc analysis of the ENRICHD data revealed that in the white males 
were younger, healthier, better educated, and less likely to live alone. The RCPP 
population was primarily younger than 65, non-diabetic, only 30% had hypertension, 
89% were married, 52 % completed college, and had lived longer than 6 months after the 
MI. Overall the populations in the two studies were markedly different; however, the 
white populations had many similarities that make comparisons within this subgroup 
worthwhile. 
One important difference across all groups is the timing of the study, including 
both the point of initiation and the duration. The ENRICHD study hypothesized that since 
the first six months post MI were the most dangerous for recurrent MI, they would begin 
the intervention immediately following the MI. Treatment lasted for six months. The 
RCPP began after six months and treatment persisted for up to 4.5 years. These 
differences raise the questions of whether an intervention would be successful when 
employed in a population likely to live past six months and whether a longer intervention 
is necessary to realize clinical results. Further differences between the studies leave room 
for exploration, and warrant research into the conflicting results. 
Some researchers feared that negative results in the ENRICHD trial would doom 
further research in the field. Closer analysis of the ENRICHD data when taken in the 
context of prior studies generates more questions for future investigation. The post hoc 
subgroup analysis demonstrated that white men received a marginal positive effect, white 
women and minority men received no effect, and minority women received a marginal 
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negative effect. Although the ENRICHD trial had statistically significant decreases in 
depression and LPSS, these differences were marginal and may not have been clinically 
significant on the order to affect CHD as demonstrated in other trials. Editorials 
questioned whether larger treatment effects and measurements of potentially synergistic 
or antagonistic variables such as hostility, negative affect, arousal, self-efficacy, and 
coping skills would offer more insight. Others recommended following sub-clinical 
markers of disease that might mediate the relationship between the psychosocial 
outcomes and medical endpoints. In light ofthis analysis, further research will be 
challenged to improve upon the ENRICHD trials comprehensive design40 41 42 43 
Critique of Literature 
In the reviewed literature, social support measures included emotional, network, 
instrumental, and perceived support. The quality of emotional support is a predictor of 
CHD progression. 2021 Social isolation is an independent predictor ofCHD mortality 
across all groups. 15 12 Those with low network social support are likely to have isolation, 
lack a confidant, have little emotional support, and have a lower perception of both social 
support and quality of support?5 High levels of expressed anger coupled with low social 
support increase risk of CHD progression (RR 3.19 over 2 years).24 Research in social 
support as related to cardiac reactivity have been inconclusive other than illustrating 
gender differences of women being more reactive to relationship-oriented topics.32 For 
patients after cardiac catheterization, lack of social support was associated with decreased 
HRQOL across all domains.33 
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Studies have attempted to increase the perception of social support, skills for 
developing and maintaining social support, and resolve internal conflicts inhibiting social 
support. Small power and post hoc analysis limit the ability to analyze the differences 
between how these interventions function in different subgroups. The ENRI CHD trial 
presents a comprehensive effort to cater the intervention to the needs of individuals; 
however, its results leave researchers asking if there is no effect, if the intervention is 
inadequate, or if they are measuring the wrong indices. The RCPP presents positive 
results in a homogenous population that limits external validity37 
The preliminary results of the ENRICHD trial may have indicated no effect of the 
interventions on reinfarction-free survival rates, but should we accept this conclusion as 
the death knoll for further research in this area? The ENRICHD trial was well-powered, 
had a diverse population, had high adherence rates, and had thorough execution of the 
interventions as designed. When we look closer, however, we can see potential 
methodological flaws in the intervention design and begin to understand the risks of 
advancing to a large effectiveness trial without the tried theoretical foundation of efficacy 
trials. 
The ideal flow of research may be of consistent efficacy trials translating to 
effectiveness trials with wide external validity. However in recent years, researchers have 
become aware of a lack of this translation to useful clinical information, and have begun 
to design effectiveness trials that might steer clinical practice. Positive results from a 
study with external validity can influence evidence-based guidelines; however, negative 
results may offer little clinical value when the moderating variables of a condition are 
poorly understood and one cannot speak to how the proposed intervention functions in 
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disease progression. Without a model that has been tested in consistent efficacy trials, 
one cannot say 'what' is not working, but rather that 'something' is not working. This 
situation has potential harms in that large effectiveness trials are expensive in terms of 
fiscal, medical, and personal resources of the participants, providers, and society. There is 
also the potential for medical harm with employing poorly understood interventions on a 
large scale. With this understanding, let us look at the ENRICHD trial from a different 
perspective. 
The researchers aimed to devise a cost-effective, generalizable intervention that 
was adaptable to the specific needs of individuals of diverse backgrounds. They based 
much of this intervention on research demonstrating that low perceived social support 
and depression were risk factors for recurrent acute myocardial infarction (AMI.) They 
intervened in the sixth month period immediately following the initial myocardial 
infarction when patients are at highest risk for recurrent AMI. 
When analyzing this study one has to ask: 
• What are the moderating variables of social support or depression influencing 
recurrent AMI? 
• Which of these variables are amenable to an intervention? 
• Which of these variables would be the most effective in changing health 
outcomes? 
• Would this list change for different populations? 
• At what point in the disease progression are different variables effective? 
• What is the required duration of intervention to sufficiently influence the key 
variables? 
• How will you measure these variables and outcomes? 
22 
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In the ENRICHD trial they assumed: 
• perception of low social support was the key variable 
• individual CBT and group therapy could shift perception of social support 
• they could adapt the intervention to different populations 
• recurrent AMI at less than six months would respond to intervention in 
similar ways as those after the high-risk period 
• this shift could be accomplished in a short period 
• the PSSS would adequately track changes and determine therapy length 
Although the researchers executed the study protocol with relative consistency 
throughout the large trial, the study protocol with its designed variability was by nature 
inconsistent. This variability could be a strength or a weakness. As a strength it is 
adaptability that broadens external validity. As a weakness, we only know that many 
different types of interventions were used to influence LPSS and that this was measured 
by the PSSS. We lack the details and final measures to determine the effects of 
moderating variables. This approach places tremendous importance on the PSSS and on 
perceived social support as the key variable. It gives us little information about other 
social support variables influencing health outcomes. Although the initial surveys to 
determine the needs of the individuals included analysis of social networking, social 
skills, etc., they have not reported final outcome measures for these variables. Most 
importantly, the researchers concluded treatment based upon the PSSS. If perceived 
social support is not actually the key variable for all populations, then this would lead to 
early termination of therapy and potentially to falsely negative results that one might 
generalize to all social support interventions in this area of research. 
Further investigation reveals that the group therapy intervention, which might be 
most effective in promoting social skills and social support, was not available to many 
participants due to timing or geographic constraints. A review of the literature reveals 
that group social support interventions typical demonstrate an initial worsening of 
symptoms and only yield their benefit after months of meeting. 50 The group intervention 
employed in this study only lasted 12 weeks at the maximum. It is likely that the 
individuals in the group therapy received an adequate intervention, and that many 
participants that could benefit from the group session did not receive this therapy at all. 
From this analysis one can see that negative findings in large effectiveness trials 
that lack the tested theoretical foundation of efficacy trials can be harmful if 
misinterpreted. Accepting their findings without investigating the theoretical 
underpinnings can potentially limit further research in a field. Such studies can 
potentially cause medical harm to patients and can consume valuable resources. 
Balancing the responsibility towards effectiveness trials with the responsibility for a 
sound theoretical basis, researchers must analyze effectiveness study methods and results 
to guide further research. The ENRICHD trial offers valuable insight into how to perform 
a large-scale behavioral intervention adapted to patient needs and how to maintain high 
adherence rates. It would be an error to accept its conclusions without further 
investigation. 
Perceived social support may not be the key variable, and interventions that 
influence variables such as social skills may be more effective. Focusing on perceived 
social support does not consider the complex dynamic of human interactions in which 
perceptions and actions are constantly changing and providing feedback. It assumes a 
pseudo-unilaterality in which the individual is either separate from the surrounding 
environment or that effects move in one direction. This false perception may be an 
artifact of our research that has not monitored social support as an interdependent system. 
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Further research will need to utilize a conceptual model that can track this interdependent 
system and find the most effect point for intervention. The following conceptual model is 
such an attempt. 
Conceptual Model 
Prior research has demonstrated a consistent relationship between measures of 
low social support and poor coronary outcomes. Other factors such as depression, trait 
hostility, outward expression of anger, cynical hostility, and depression have performed 
as independent predictors of cardiac morbidity and mortality in some trials. Studies have 
attempted to clarify the relationship of these factors with elements of social support, and 
their physiologic mechanism of action in CHD progression. Mixed results in these efforts 
have raised questions about how these factors interact differently in various subgroups. 
These conflicting results may serve to draw out the mechanism of action when the 
characteristics of the groups are considered. 
The following conceptual model provides an outline for further research. The 
model presents the different types of social support acting through physiologic responses 
to affect CHD. The mechanism of interaction may occur through perceptual changes or 
through the fulfillment of basic human needs for connection, reassurance, validation, and 
support. Gender and race moderate this effect through unknown mechanisms that may be 
the result of unique cultural perceptions, functions of support within those groups, or 
physiologic differences in stress response. Social support also acts through the mediating 
variable of health behaviors that affect physiologic responses directly. Hostility is an 
independent actor through physiologic response on CHD. It also has an indirect effect 
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through decreasing social support as outlined above. Depression is an independent 
predictor acting through physiologic responses, and it also has an interaction with social 
support in which social support may decrease depression or depression may cause 
withdrawal from social support. 
Genetics or heredity exerts a direct influence on the tendency toward depression 
or exaggerated physiologic response. This effect may be closely linked with culture, race, 
and gender. When considering the effects of culture, race and gender, the interaction may 
be complex and may influence reporting. For instance cultural norms of hostility 
expression may affect the frequency of the behavior, its perception, and its scoring on 
self-report forms. These unique characteristics of subgroups may prove important in 
creating interventions that fit the dynamics of each population. 
The model below presents a simplified interaction of predictive variables with 
CHD progression. The text boxes below the flow diagram detail elements within each 
variable. These elements represent potential outcome measurements for a study and such 
data may help to clarify the complex interactions of social support and CHD in males. 
Appreciating this complexity we must understand that these interactions occur within the 
context of culture which may influence the magnitude and direction of effect through the 
moderator of perception. 
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Conceptual Model for Interaction of Predictive Variables with Coronary Artery Disease 
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From the literature it is apparent more than perception of social support is 
important in the relationship of social support and CHD. Appreciating the complexity 
and interdependence, one must consider how to affect social skills, perception of support, 
emotional support, and network support. Would it be possible to affect them all or would 
it be more feasible to focus on one? Without an understanding of how the variables 
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interact, it may not be possible to isolate the most effective variable until an exploratory 
study has tested the model. One must also consider what outcomes to measure, the 
duration of the study, and what would be the most appropriate setting for intervention and 
measurement. Finally, given that those most in need of the intervention will likely be the 
most resistant to participate, how can one overcome this challenge of enrollment? 
The proposed study incorporates a relatively new practice model that has 
developed for the treatment of chronic disease. The development began at Kaiser 
Permanente when John Scott developed the Cooperative Health Care Clinic (CHCC) in 
1990.44 45 This model, which has subsequently become known as the group visit, 
combines individual medical care, guided discussion, and a support group.46 This model 
could present an ideal setting for a facilitator to teach social skills in a group environment 
while also using Cognitive Behavioral Therapy methods to shift perceptions of! ow social 
support. If well facilitated over a sufficient duration, the group visit can become a source 
of emotional support. 
Typically the group visits involve a period of obtaining clinical data such as 
measuring vitals or registering new complaints. These periods would be an opportunity to 
collect data throughout the course of the study, including lab values of physiologic 
responses such blood pressure, cortisol levels to monitor stress, or lipid levels to monitor 
cholesterol. The ability to collect such data throughout the course of the study would be 
valuable in clarifying the interaction of mediating variables, physiologic responses, and 
coronary outcomes. 
Success in group visits has been dependent on a competent facilitator and the 
ability to frame the meeting as a medical clinic visit.44 Successfully framing the visit as 
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such may address the enrollment challenges mentioned earlier. The reluctant participants 
may be more likely to attend something labeled as a clinic visit that offers more time with 
the provider, than an intervention thought of as optional, additional, or as unneeded. 
Borrowing from the positive aspects of the ENRICHD trial, investigators could utilize 
their enrollment techniques such as telephone follow-ups to decrease attrition and 
improve participation. 
Various methods may counter the weaknesses of the ENRICHD trial. The 
proposed study would need to at least measure the levels of emotional, network, and 
perceived support at enrollment and at conclusion in order to understand how these 
variables interact and influence CHD progression. If researchers were to monitor this data 
throughout the course of the study, they could correlate the fluctuations with the clinical 
data and markers of physiologic responses. This comprehensive data set would allow a 
thorough analysis of the interaction in the conceptual model. Multiple linear regression 
modeling could clarify interactions and independent variables. Researchers would need to 
find a balance where such comprehensive data collection does not inhibit the 
functionality of the intervention. 
In the group visit model a competent facilitator could teach social skills, provide a 
safe environment to practice these skills, and address obstacles to effective 
communication and emotional support. Proponents of group visits claim that the visits 
have proven effective for improving patient education and compliance.47 Masley et al. 
have outlined a group visit plan for such high-risk groups, and have successfully 
implemented a dietary change intervention in a group visit model of individuals with 
CHD. 48 49 
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Again, the facilitator would need to normalize these sessions and frame them in a 
non-threatening, appealing context that participants can view as an integral part of their L 
medical care. The participants would need to know that they would still have independent 
time with their provider, and that these sessions are an essential complement to their care I 
L 
that actually affords them more services from their health care team. To encourage 
participation and investment in the intervention, the facilitator may take suggestions from 
the group for designing the content of their future education components. It may be 
possible to have participants take turns as co-facilitators or planners of the sessions. The 
skillful clinical facilitator could utilize these opportunities as teachable moments to help 
with social skills such as communication and self-confidence. Another aspect to aid 
participation that could augment emotional and network support is a buddy system in 
which each group member is paired with another and is responsible for calling weekly to 
check on progress or challenges. Such pairings are likely to generate some level of 
discomfort and conflict, and it would be up to the facilitator to utilize these instances as 
opportunities to learn new skills or shift perceptions. 
As mentioned earlier, support group interventions may initially demonstrate 
worse outcomes and need a sufficient duration to have a positive effect. 5° The support 
group is a critical aspect of the group visit, and because of this structure, the study would 
need to run longer than the brief period allotted in the ENRICHD trial. Typically group 
visits enroll 8-20 participants and ideally the study would continue the intervention for at 
least one year.44 The proposed study would enroll 8-12 participants per group and each 
group would meet twice monthly for the first two months, and then once monthly for the 
remaining ten. 
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In summary, the intervention would be based in a group visit format enrolling 8-
12 participants per group and meeting for a total of 14 visits over the duration of a year. 
The visits will be an integral part of their medical care and will provide time for 
individual medical care or questions. The group visit format would provide an 
environment to teach healthy behaviors, social skills, provide emotional and network 
support, and shift negative perceptions of social support. Participants will aid in devising 
the content of the educational component of the future group visits and will be 
encouraged to co-facilitate a future session. The visit will have a component of open 
discussion that functions as a support group to answer group questions about CHD or 
express emotions around challenges and successes. Each participant will be paired with a 
buddy in their group whom they will contact once weekly to check on progress and 
challenges. 
This interaction will also provide an opportunity to practice social skills and to 
cultivate emotional support. The intervention will present predictable challenges to the 
participants, and it will be the role of a skillful facilitator to utilize these moments as 
learning opportunities to acquire new skills, shift negative perceptions, and open to 
empathetic support. 
The study will measure perceived support through the Perceived Social Support 
Scale (PSSS), network support through the Mannheim Social Support Interview, hostility 
through the State Trait Anger Expression Inventory (ST AX!), emotional support through 
the Inventory of Socially Supportive Behaviors (ISSB), and health related QOL through 
the Medical Outcomes Study 36-item Short Form (MOS SF-36). The investigators will 
repeat these measures at three-month intervals for a total of four measurements, including 
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the conclusion of the intervention. During each group visit investigators will monitor 
blood pressure, serum cholesterol, and serum cortisol level. Participants will complete a 
brief inventory investigating health behaviors including diet, exercise, and medication 
compliance at each session. This comprehensive data set will provide information 
throughout the course of the study that will allow for comparison of interactions in the 
conceptual model. The following table details the reliability and validity of these tools. 
Summary Table of Measure Characteristics: 
Tool Measure Validitv Reliability Source 
Perceived Social Perceived Support Good Good Dahlem NW, Zimet 
Support Scale (PSS) GO, Walker RR. The 
Multidimensional Scale 
of Perceived Social 
Support: a confinnation 
study. J Clin Psycho!. 
1991 NovA7l6):756-
61. 
Mannheim Social Network Support Good Good Veiel HO. The 
Support Interview Mannheim Interview on 
Social Support 
Reliability and validity 
data !fom three 
samples. Soc Psychiatry 
Psychiatr Epidemiol 
1990 Sep;:25(5):250-9. 
State Trait Anger Hostility Adequate Adequate 
Expression Inventory Reyes LR, Meininger 
(STAXI) JC, Liehr P, Chan W, 
Mueller WH_ Anger in 
adolescents: sex, 
ethnicity, age 
differences. and 
psychometric 
properties. Nurs Res. 
2003 Jan.feb;52( 1 ):2-
11 
Inventory of Socially Emotional Support Good Good Barrera M. Distinctions 
Supportive Behaviors between social support 
(ISSB) concepts, measures and 
models. Am J 
Community Psychol. 
1986; 9:435--447. 
BECK Depression Depression Good Good AT. Beck, C. H. Ward, 
Inventory M. Mendelsohn, .1. 
Mock and .1. Erbaugh, 
An inventory for 
measuring depression. 
Arch Gen Psychiat1y 
(1961), pp. 561-571 
Medical Outcomes Quality of Life Good Good Ware J, Sherbourne C. 
Study Short Form The MOS 36-item 
(MOS SF-36) short-fOrm health 
survey (SF-36). Med 
Care. 1992;30:473---
483. 
Scale: poor-adequate-good 
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Potential weaknesses of this intervention arise from its comprehensive nature, 
reliance on the skillful facilitation of a provider, challenges with participation, and 
potential challenges with external validity in the current medical environment. An initial 
pilot of the study including twelve groups may be helpful for testing feasibility before 
expanding to a larger trial. This low enrollment of 96-144 participants may not provide 
the necessary power for all of the subgroup analyses; however, it would provide guidance 
for adjusting the intervention to a larger scale. To expand to the larger trial the 
researchers would mirror the power calculations of the ENRICHD trial. They would have 
a target sample size of 3000 participants to yielded an 88% power to detect a 30% person 
difference in complying patients or an observed treatment effect of 24% in all patients. 
Randomization would use a block algorithm, varying block sizes by 2, 4, and 6.51 The 
comprehensive data set from this expanded trial would provide many opportunities for 
hypothesis testing and for analyzing intervention effects in predefined sub-groups of race, 
gender, support type, and depression. 
Without a successful facilitator, participation may wane and the participants may 
not acquire new skills, support, or perceptions. Care must be taken in choosing, training, 
and monitoring facilitators throughout the course of the study. In early group visits up to 
30-50% of patients did not want to participate.44 The investigators will need to address 
this enrollment challenge through active framing and creative methods in order to reach 
those patients which may need the intervention the most but may be reluctant to 
participate. Finally, providers have faced difficulty with reimbursement for group visits 
and have had most success in large HMO environments. Unless the medical environment 
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changes or providers find a way to successfully bill for group visits, feasibility may be 
limited to these HMO environments. 
From the literature summary, one can see possible influences of social support on 
the progression of CHD. Currently researchers do not understand this relationship or how 
to intervene to improve health outcomes. The literature has explored numerous variables 
in this complex relationship and these studies have been unable to clarify the interactions 
of the moderating variables. The ENRICHD trial attempted a cost-effective intervention 
to improve cardiac outcomes, however this effectiveness trial had methodological flaws 
that left researchers unsure of how to interpret its negative outcomes. The proposed study 
and conceptual model attempt to address the weaknesses of the ENRICHD trial while 
incorporating its strengths. The study will provide a foundation for devising a larger trial 
in which analysis of the comprehensive data set may reveal the interactions of variables 
in the progression of CHD. Understanding this interaction will provide the theoretical 
basis for designing future interventions that may translate to effective programs for 
reducing recurrent myocardial infarction in high-risk groups. 
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